MEBT/MEBO in
treating Penis and Scrotum skin soft tissue laceration
Male external genital organs mainly consist of
penis and
scrotum.
Because the parts are located at concealed
positions and have
more wrinkles, it is not easy to remove necrotic tissue layers on
wounds[2] after injured.
However, the application of MEBO can liquefy
and discharge the necrotic tissues on wounds to guarantee the
clear and
free drainage of the wounds.
Simultaneously, a moist
physiological
environment is formed around the wounds, which starts the
growth of
stem cells on wounds to regenerate
skin tissues in situ .
This ensures
the wounds healing in the shortest time. The average healing time of
the treatment group was 7.5 days.
Penis and scrotum at perineum, as one of the
sensitive
parts of human body, are easy to feel violently pain after injured for
there are abundant blood vessels, nerves and voluntary muscles.
MEBO
supplies a moist
physiological environment around the wounds which can
protect the pain nerve terminals from the stimulations of dry
environment and improve the microcirculation of tissues to abate the
stimulations and pressures toward the nerve terminals caused by hypoxia
and edema.
As a result, MEBO, with acesodyne and anti -itch
functions,
can quickly lessen the pain of the wounds.
After drug application,
cases with pain alleviated in 5 minutes account for 63.88% of the
treatment group.
Penis and scrotum at perineum are the areas easy
to be
contaminated by stool and urine.
The application of MEBO can not only
protect and isolate the wounds from direct contaminations by stool and
urine to reduce the contaminative chances of wound environment, but
also can freely drain, prevent and treat internal issues and the
infections caused by liquefied matters on the wounds to provide an
environment as flowing water does not get stale to the wounds.
The
moist environment can help liquefy and discharge the necrotic tissues
from the superficies to the interior to avoid the absorbtion of toxins
through the wounds, so it provides a fine environment for the viability
of survival epidermis tissues. β—sitosterol and
other
components contained in MEBO
have anti-inflammatory action because they
interact with substrate to make bacterium mutate and lose toxicity
quickly to become non-invasiveness.
MEBO can inhibit
and control the
growth and reproduction of all the general pathogens to
achieve the
anti-inflammatory functions[3]. The infection rate of the treatment
group was merely 5.55%.
MEBO can reduce
inflammatory reaction of wounds
and
overcome the negative stimulations to the wounds that treated by
occlusive dressing, during which the wounds are will mechanically
injured when wound dressings are changed, so it lessens the scar
formation on the wounds.
MEBO can get rid of hyper-oxyradical which
impacts the stability of tissues,
better the partial environment of
oxygen supply around the wounds and promote the
integrative healing of
the wounds so as to reduce scar formation.
MEBO regulates and controls
the hyperplasia and arrangement order of celluloses to make epithelium
of survival glands regenerate and differentiate to basal layer cells in
surface layer, and finally the wounds epithelized healgradually.
This
complies to the rules of skin natural regenerative repair, reduces scar
hyperplasia[4] and obviously decreases the disability rate.
Three cases
in the control group while none in the treatment group underwent
erection dysfunction caused by the contracture and malunion of the
scars on the penis.
In the treatment group, the side effects of local
discomfort, such as contact
dermatitis and pain caused by MEBO were
evidently lower than that in the control group.
This shows that MEBO is
the preferred external used medicine because it provides an ideal
effect with low side effect in treating contused & lacerated
wounds
of the skin soft tissues.
MEBT/MEBO is the best method for treating penis
and scrotum skin soft tissue laceration.
Full Report: Experience with
MEBT/MEBO in treating penis and scrotum skin soft tissue laceration,
The Chinese Journal of Burns Wounds and Surface Ulcers 2003, (4):
330-332
|